Bone Marrow Engraftment in a Rodent Model of Chemical Carcinogenesis but No Role in the Histogenesis of Hepatocellular Carcinoma

Overview

Journal Gut

Specialty Gastroenterology

Date 2004 May 13

PMID 15138218

Citations 15

Authors

H Ishikawa

K Nakao

K Matsumoto

D Nishimura

T Ichikawa

K Hamasaki

K Eguchi

Affiliations

Soon will be listed here.

Abstract

Background And Aim: Recent studies indicated that hepatic stem cells in the bone marrow could differentiate into mature hepatocytes, suggesting that bone marrow cells could be used for replacement of damaged hepatocytes in a variety of liver diseases. Hepatocellular carcinoma (HCC) is thought to arise from hepatic stem cells. In this study, we investigated the malignant potential of hepatic stem cells derived from the bone marrow in a mouse model of chemical hepatocarcinogenesis.

Methods: Bone marrow cells were obtained from the male beta-galactosidase (beta-gal) transgenic mouse and transplanted into female recipient mice. Hepatocarcinogenesis was induced by a year of treatment with diethylnitrosamine and phenobarbital (NDEA/PB). One year later, the liver was removed from each treated mouse and evaluated by x-gal staining, immunohistochemistry, and fluorescence in situ hybridisation (FISH).

Results: Forty per cent of recipient mice survived and developed multiple HCC. Clusters of beta-gal positive mature hepatocytes were detected sporadically in the entire liver of NDEA/PB treated mice who underwent bone marrow transplantation (BMT) with while no such hepatocytes were identified in the liver of BMT mice that were not treated with NDEA/PB. The Y chromosome was detected with the same frequency as the donor male liver in clusters of beta-gal positive mature hepatocytes by FISH. However, no HCC was positive for beta-gal or the Y chromosome. Immunohistochemically, beta-gal positive mature hepatocytes did not express CD34 or alpha-fetoprotein.

Conclusions: Our results suggest that hepatic stem cells derived from the bone marrow have low malignant potential, at least in our model.

Citing Articles

Cancer stem cells of hepatocellular carcinoma.

Wang K, Sun D Oncotarget. 2018; 9(33):23306-23314.

PMID: 29796190 PMC: 5955417. DOI: 10.18632/oncotarget.24623.

Supportive therapies for prevention of hepatocellular carcinoma recurrence and preservation of liver function.

Takami T, Yamasaki T, Saeki I, Matsumoto T, Suehiro Y, Sakaida I World J Gastroenterol. 2016; 22(32):7252-63.

PMID: 27621572 PMC: 4997645. DOI: 10.3748/wjg.v22.i32.7252.

Adipose-Derived Mesenchymal Stem Cell Exosomes Suppress Hepatocellular Carcinoma Growth in a Rat Model: Apparent Diffusion Coefficient, Natural Killer T-Cell Responses, and Histopathological Features.

Ko S, Yip H, Zhen Y, Lee C, Lee C, Huang C Stem Cells Int. 2015; 2015:853506.

PMID: 26345219 PMC: 4545422. DOI: 10.1155/2015/853506.

Role of Bone Marrow-Derived Stem Cells in Polyps Development in Mice with Apc(Min/+) Mutation.

Barone M, Scavo M, Licinio R, Piombino M, De Tullio N, Mallamaci R Stem Cells Int. 2015; 2015:354193.

PMID: 26167184 PMC: 4488009. DOI: 10.1155/2015/354193.

Are hematopoietic stem cells involved in hepatocarcinogenesis?.

Facciorusso A, Antonino M, Del Prete V, Neve V, Scavo M, Barone M Hepatobiliary Surg Nutr. 2014; 3(4):199-206.

PMID: 25202697 PMC: 4141297. DOI: 10.3978/j.issn.2304-3881.2014.06.02.

References

Chen C, Chen D . Interaction of hepatitis B virus, chemical carcinogen, and genetic susceptibility: multistage hepatocarcinogenesis with multifactorial etiology. Hepatology. 2002; 36(5):1046-9. DOI: 10.1053/jhep.2002.37084. View

Petersen B, BOWEN W, Patrene K, Mars W, Sullivan A, Murase N . Bone marrow as a potential source of hepatic oval cells. Science. 1999; 284(5417):1168-70. DOI: 10.1126/science.284.5417.1168. View

Sell S . Cellular origin of hepatocellular carcinomas. Semin Cell Dev Biol. 2002; 13(6):419-24. DOI: 10.1016/s1084952102001295. View

Wang X, Willenbring H, Akkari Y, Torimaru Y, Foster M, Al-Dhalimy M . Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature. 2003; 422(6934):897-901. DOI: 10.1038/nature01531. View

Vassilopoulos G, Wang P, Russell D . Transplanted bone marrow regenerates liver by cell fusion. Nature. 2003; 422(6934):901-4. DOI: 10.1038/nature01539. View

Newsome P, Johannessen I, Boyle S, Dalakas E, McAulay K, Samuel K . Human cord blood-derived cells can differentiate into hepatocytes in the mouse liver with no evidence of cellular fusion. Gastroenterology. 2003; 124(7):1891-900. DOI: 10.1016/s0016-5085(03)00401-3. View

Theise N . Liver stem cells: the fall and rise of tissue biology. Hepatology. 2003; 38(4):804-6. DOI: 10.1053/jhep.2003.50465. View

POTTER V . Phenotypic diversity in experimental hepatomas: the concept of partially blocked ontogeny. The 10th Walter Hubert Lecture. Br J Cancer. 1978; 38(1):1-23. PMC: 2009671. DOI: 10.1038/bjc.1978.159. View

Ward J . Morphology of hepatocellular neoplasms in B6C3F1 mice. Cancer Lett. 1980; 9(4):319-25. DOI: 10.1016/0304-3835(80)90024-5. View

10.

Goodman Z, Ishak K, Langloss J, Sesterhenn I, Rabin L . Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study. Cancer. 1985; 55(1):124-35. DOI: 10.1002/1097-0142(19850101)55:1<124::aid-cncr2820550120>3.0.co;2-z. View

11.

Tsao M, Grisham J . Hepatocarcinomas, cholangiocarcinomas, and hepatoblastomas produced by chemically transformed cultured rat liver epithelial cells. A light- and electron-microscopic analysis. Am J Pathol. 1987; 127(1):168-81. PMC: 1899598. View

12.

Braun L, Mikumo R, Fausto N . Production of hepatocellular carcinoma by oval cells: cell cycle expression of c-myc and p53 at different stages of oval cell transformation. Cancer Res. 1989; 49(6):1554-61. View

13.

Sell S, Dunsford H . Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma. Am J Pathol. 1989; 134(6):1347-63. PMC: 1879951. View

14.

Liu R, Baldwin B, Tennant B, Hotchkiss J . Elevated formation of nitrate and N-nitrosodimethylamine in woodchucks (Marmota monax) associated with chronic woodchuck hepatitis virus infection. Cancer Res. 1991; 51(15):3925-9. View

15.

Friedrich G, Soriano P . Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice. Genes Dev. 1991; 5(9):1513-23. DOI: 10.1101/gad.5.9.1513. View

16.

Aterman K . The stem cells of the liver--a selective review. J Cancer Res Clin Oncol. 1992; 118(2):87-115. DOI: 10.1007/BF01187498. View

17.

Liu R, Jacob J, Tennant B, Hotchkiss J . Nitrite and nitrosamine synthesis by hepatocytes isolated from normal woodchucks (Marmota monax) and woodchucks chronically infected with woodchuck hepatitis virus. Cancer Res. 1992; 52(15):4139-43. View

18.

Sell S . The role of determined stem-cells in the cellular lineage of hepatocellular carcinoma. Int J Dev Biol. 1993; 37(1):189-201. View

19.

Anilkumar T, Golding M, Edwards R, Lalani E, Sarraf C, Alison M . The resistant hepatocyte model of carcinogenesis in the rat: the apparent independent development of oval cell proliferation and early nodules. Carcinogenesis. 1995; 16(4):845-53. DOI: 10.1093/carcin/16.4.845. View

20.

Thorgeirsson S . Hepatic stem cells in liver regeneration. FASEB J. 1996; 10(11):1249-56. View